[{"NetIncomeLoss_2_Q2_USD":-169514000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":37825000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":19779000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":43356207.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":43825723.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":11284000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-144674000.0,"Depreciation_1_Q2_USD":100000.0,"Depreciation_2_Q2_USD":253000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":323977000.0,"MarketableSecuritiesCurrent_0_Q2_USD":514021000.0,"PaymentsToAcquireInvestments_2_Q2_USD":384127000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":56843000.0,"AssetsCurrent_0_Q2_USD":654037000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":11804131.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":11736603.0,"CommonStockSharesIssued_0_Q2_shares":44482308.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":514021000.0,"Assets_0_Q2_USD":663950000.0,"ShareBasedCompensation_2_Q2_USD":42354000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":700000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":3000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":323977000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":1577000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":136791000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":65083000.0,"PrepaidExpenseCurrent_0_Q2_USD":5043000.0,"AssetsFairValueDisclosure_0_Q2_USD":645710000.0,"ProceedsFromStockPlans_2_Q2_USD":524000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":4835000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":2003000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":863000.0,"CommonStockValue_0_Q2_USD":45000.0,"Revenues_2_Q2_USD":267000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":1395000.0,"Revenues_1_Q2_USD":0.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":-1029000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":348474000.0,"RestrictedCash_0_Q2_USD":620000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-168119000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-81282000.0,"OtherAssetsNoncurrent_0_Q2_USD":6726000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":131689000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":240878000.0,"Liabilities_0_Q2_USD":58946000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":23932000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":8803000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":409000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":20787000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":42354000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-118347000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_2_Q2_USD":23932000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q2_USD":8749000.0,"LiabilitiesCurrent_0_Q2_USD":57695000.0,"AccountsPayableCurrent_0_Q2_USD":24099000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":132309000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8327000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":23900000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1765000.0,"ProceedsFromStockOptionsExercised_1_Q2_USD":8700000.0,"AdditionalPaidInCapital_0_Q2_USD":1535490000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":820310.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q2_shares":323789.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":524000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":524000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":239000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3187000.0,"NetIncomeLoss_1_Q2_USD":-82859000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":131689000.0,"InterestReceivableCurrent_0_Q2_USD":1813000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1282000.0,"RestrictedCashNoncurrent_0_Q2_USD":600000.0,"OperatingIncomeLoss_2_Q2_USD":-174349000.0,"OperatingIncomeLoss_1_Q2_USD":-84862000.0,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":663950000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5081000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":42354000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":20787000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":4469000.0,"OperatingExpenses_2_Q2_USD":174616000.0,"InvestmentsFairValueDisclosure_0_Q2_USD":514021000.0,"OperatingExpenses_1_Q2_USD":84862000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.89,"OtherLiabilitiesNoncurrent_0_Q2_USD":1251000.0,"StockholdersEquity_0_Q2_USD":605004000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1425000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":512259000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":267000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-941815000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":85453000.0,"CommonStockSharesOutstanding_0_Q2_shares":44482308.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-3.91,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":9092873.0,"Ticker":"MRTX","CIK":"1576263","name":"MIRATI THERAPEUTICS, INC.","OfficialName":"Mirati Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"4261498445.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]